DK1224164T3 - Hydroxaminsyrederivat som inhibitor for produktion af oplöselig human CD23 - Google Patents
Hydroxaminsyrederivat som inhibitor for produktion af oplöselig human CD23Info
- Publication number
- DK1224164T3 DK1224164T3 DK00975954T DK00975954T DK1224164T3 DK 1224164 T3 DK1224164 T3 DK 1224164T3 DK 00975954 T DK00975954 T DK 00975954T DK 00975954 T DK00975954 T DK 00975954T DK 1224164 T3 DK1224164 T3 DK 1224164T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitor
- production
- acid derivative
- hydroxamic acid
- soluble human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9925470.8A GB9925470D0 (en) | 1999-10-27 | 1999-10-27 | Novel compounds |
| PCT/EP2000/010649 WO2001030747A1 (en) | 1999-10-27 | 2000-10-25 | Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 |
| EP00975954A EP1224164B1 (en) | 1999-10-27 | 2000-10-25 | Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1224164T3 true DK1224164T3 (da) | 2005-03-29 |
Family
ID=10863507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00975954T DK1224164T3 (da) | 1999-10-27 | 2000-10-25 | Hydroxaminsyrederivat som inhibitor for produktion af oplöselig human CD23 |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US6673965B1 (es) |
| EP (1) | EP1224164B1 (es) |
| JP (1) | JP3922431B2 (es) |
| KR (1) | KR20020044578A (es) |
| CN (1) | CN1182107C (es) |
| AR (1) | AR026244A1 (es) |
| AT (1) | ATE284382T1 (es) |
| AU (1) | AU766072B2 (es) |
| BR (1) | BR0015082A (es) |
| CA (1) | CA2389319A1 (es) |
| CO (1) | CO5261576A1 (es) |
| CZ (1) | CZ20021424A3 (es) |
| DE (1) | DE60016622T2 (es) |
| DK (1) | DK1224164T3 (es) |
| ES (1) | ES2233474T3 (es) |
| GB (1) | GB9925470D0 (es) |
| GC (1) | GC0000142A (es) |
| HK (1) | HK1049146A1 (es) |
| HU (1) | HUP0203270A3 (es) |
| IL (1) | IL149364A0 (es) |
| MX (1) | MXPA02004228A (es) |
| MY (1) | MY133601A (es) |
| NO (1) | NO20021965L (es) |
| NZ (1) | NZ518566A (es) |
| PE (1) | PE20010898A1 (es) |
| PL (1) | PL356524A1 (es) |
| PT (1) | PT1224164E (es) |
| SI (1) | SI1224164T1 (es) |
| TW (1) | TW561141B (es) |
| UY (1) | UY26416A1 (es) |
| WO (1) | WO2001030747A1 (es) |
| ZA (1) | ZA200203255B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010032147A2 (en) * | 2008-09-19 | 2010-03-25 | Pfizer Inc. | Hydroxamic acid derivatives useful as antibacterial agents |
| WO2011068853A2 (en) | 2009-12-01 | 2011-06-09 | Boston Medical Center Corporation | TREATMENT OF IgE-MEDIATED DISEASE |
| JP5793766B2 (ja) | 2009-12-16 | 2015-10-14 | ファイザー・インク | 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体 |
| GEP20156370B (en) | 2011-03-07 | 2015-09-25 | Pfizer | Fluoro-pyridinone derivatives useful as antibacterial agents |
| CA2830920C (en) | 2011-04-08 | 2015-07-14 | Pfizer Inc. | Isoxazole derivatives useful as antibacterial agents |
| AU2012238379C1 (en) | 2011-04-08 | 2015-08-06 | Pfizer Inc. | Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
| EP2525213A1 (en) * | 2011-05-16 | 2012-11-21 | Renishaw plc | Spectroscopic apparatus and methods for determining components present in a sample |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9513331D0 (en) | 1995-06-30 | 1995-09-06 | British Biotech Pharm | Matrix metalloproteinase inhibitors |
| GB9813451D0 (en) * | 1998-06-22 | 1998-08-19 | Smithkline Beecham Plc | Novel compounds |
-
1999
- 1999-10-27 GB GBGB9925470.8A patent/GB9925470D0/en not_active Ceased
-
2000
- 2000-10-25 CN CNB008173680A patent/CN1182107C/zh not_active Expired - Fee Related
- 2000-10-25 AR ARP000105622A patent/AR026244A1/es not_active Application Discontinuation
- 2000-10-25 GC GCP2000972 patent/GC0000142A/xx active
- 2000-10-25 CA CA002389319A patent/CA2389319A1/en not_active Abandoned
- 2000-10-25 CZ CZ20021424A patent/CZ20021424A3/cs unknown
- 2000-10-25 WO PCT/EP2000/010649 patent/WO2001030747A1/en active IP Right Grant
- 2000-10-25 JP JP2001533102A patent/JP3922431B2/ja not_active Expired - Fee Related
- 2000-10-25 EP EP00975954A patent/EP1224164B1/en not_active Expired - Lifetime
- 2000-10-25 US US10/111,209 patent/US6673965B1/en not_active Expired - Fee Related
- 2000-10-25 SI SI200030603T patent/SI1224164T1/xx unknown
- 2000-10-25 PL PL00356524A patent/PL356524A1/xx unknown
- 2000-10-25 NZ NZ518566A patent/NZ518566A/en unknown
- 2000-10-25 AU AU13895/01A patent/AU766072B2/en not_active Ceased
- 2000-10-25 PT PT00975954T patent/PT1224164E/pt unknown
- 2000-10-25 AT AT00975954T patent/ATE284382T1/de not_active IP Right Cessation
- 2000-10-25 BR BR0015082-7A patent/BR0015082A/pt not_active IP Right Cessation
- 2000-10-25 HU HU0203270A patent/HUP0203270A3/hu unknown
- 2000-10-25 DK DK00975954T patent/DK1224164T3/da active
- 2000-10-25 KR KR1020027005340A patent/KR20020044578A/ko not_active Application Discontinuation
- 2000-10-25 DE DE60016622T patent/DE60016622T2/de not_active Expired - Lifetime
- 2000-10-25 IL IL14936400A patent/IL149364A0/xx unknown
- 2000-10-25 MX MXPA02004228A patent/MXPA02004228A/es active IP Right Grant
- 2000-10-25 MY MYPI20005012A patent/MY133601A/en unknown
- 2000-10-25 UY UY26416A patent/UY26416A1/es not_active Application Discontinuation
- 2000-10-25 ES ES00975954T patent/ES2233474T3/es not_active Expired - Lifetime
- 2000-10-26 CO CO00081571A patent/CO5261576A1/es not_active Application Discontinuation
- 2000-10-26 TW TW089122497A patent/TW561141B/zh active
- 2000-10-27 PE PE2000001156A patent/PE20010898A1/es not_active Application Discontinuation
-
2002
- 2002-04-24 ZA ZA200203255A patent/ZA200203255B/en unknown
- 2002-04-25 NO NO20021965A patent/NO20021965L/no unknown
- 2002-12-19 HK HK02109235A patent/HK1049146A1/xx not_active IP Right Cessation
-
2003
- 2003-10-03 US US10/678,679 patent/US20040077727A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20010686L (no) | Hydroksypipecolathydroksyaminsyrederivater som MMP inhibitorer | |
| NO20031797L (no) | Heteroarylalkylpiperazin-derivater som fettsyreoksidasjonsinhibitorer | |
| NO20030867D0 (no) | Hydroksamderivater anvendelig som deacetylaseinhibitorer | |
| CY2009011I2 (el) | Αλατα προσθηκης οξεος παραγωγων υδροπυριδινης | |
| DK1460066T3 (da) | Piperazinforbindelse som tachykinin-inhibitorer | |
| DE60035631D1 (de) | Inhibitoren der Interleukin-4 Produktion | |
| NO20022125D0 (no) | Pyrrolderivater som inhibitorer for fosfodiesterase VII | |
| IS6987A (is) | Nýjar súlfónsýru afleiður | |
| HK1073102A1 (en) | Sulphonic acid salts of mandelic acid derivatives | |
| DE60043730D1 (de) | Arylsulfonamid-substituierte hydroxamsäure-derivate | |
| NO20016201D0 (no) | Tienopyrimidiner som fosfodiesteraseinhibitorer | |
| NO20021959L (no) | Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer | |
| DK1224164T3 (da) | Hydroxaminsyrederivat som inhibitor for produktion af oplöselig human CD23 | |
| NO20022123D0 (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII | |
| NO20043084L (no) | 3-fenyl-2-arylalkyltiopropionsyre derivater som selektive agnoister av PPAR-ALPHA | |
| ATE262517T1 (de) | Thiopyranderivate as mmp-inhibitoren | |
| NO20016403D0 (no) | Substituerte purinderivater som inhibitorer av celleadhesjon | |
| DK1089963T3 (da) | Hydroxamsyrederivater som inhibitorer af produktion af humant CD23 og af TBF-frigivelse | |
| DK1497290T3 (da) | Fremgangsmåde til fremstilling af syresalte af gemifloxacin | |
| DK1438286T3 (da) | Fremgangsmåde til fremstilling af arylsulfonsyreisocyanater | |
| AU2000265100A1 (en) | N sulfonyl aminoacid derivatives as inhibitors of metalloproteinase | |
| EE200100448A (et) | Bifenüül-2-karboksüülhappe derivaatide valmistamise meetod | |
| NO20025740D0 (no) | Karbaminsyreestere som inhibitorer for faktor Xa | |
| EE04960B1 (et) | Meetod arliminometlkarbamiinhappeestrite valmistamiseks | |
| PL375413A1 (en) | Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |